Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Moderate to Severe Rheumatoid Arthritis”

150 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 150 results

Not applicableStudy completedNCT05323591
What this trial is testing

Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France

Who this might be right for
Rheumatoid Arthritis
Alfasigma S.p.A. 155
Large-scale testing (Phase 3)Study completedNCT02057250
What this trial is testing

To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis

Who this might be right for
RA
Sanofi 217
Testing effectiveness (Phase 2)Study completedNCT03823391
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 48
Testing effectiveness (Phase 2)Study completedNCT05198310
What this trial is testing

Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor

Who this might be right for
Arthritis, Rheumatoid
Kiniksa Pharmaceuticals, Ltd. 145
Large-scale testing (Phase 3)Study completedNCT03086343
What this trial is testing

Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 657
Large-scale testing (Phase 3)Study completedNCT06048224
What this trial is testing

Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Active Rheumatoid Arthritis
Zhejiang Hisun Pharmaceutical Co. Ltd. 669
Testing effectiveness (Phase 2)Temporarily pausedNCT00777816
What this trial is testing

Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
XOMA (US) LLC 18
Testing effectiveness (Phase 2)Study completedNCT05957107
What this trial is testing

Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Beijing VDJBio Co., LTD. 181
Testing effectiveness (Phase 2)Study completedNCT02065700
What this trial is testing

Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 739
Not applicableActive Not RecruitingNCT04871919
What this trial is testing

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Alfasigma S.p.A. 1,304
Testing effectiveness (Phase 2)Looking for participantsNCT07423533
What this trial is testing

Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD

Who this might be right for
Rheumatoid Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd. 450
Large-scale testing (Phase 3)Study completedNCT04171414
What this trial is testing

Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 62
Large-scale testing (Phase 3)Study completedNCT03357471
What this trial is testing

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderate and Severe Active Rheumatoid ArthritisActive Psoriatic ArthritisActive Ankylosing Spondylitis+1 more
UCB Biopharma S.P.R.L. 70
Testing effectiveness (Phase 2)Study completedNCT04634253
What this trial is testing

LY3462817 in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 98
Large-scale testing (Phase 3)Study completedNCT00535782
What this trial is testing

The Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 132
Testing effectiveness (Phase 2)Study completedNCT03813199
What this trial is testing

Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abivax S.A. 60
Large-scale testing (Phase 3)Study completedNCT01710358
What this trial is testing

A Study in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 1,307
Large-scale testing (Phase 3)Study completedNCT03980483
What this trial is testing

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 1,537
Early research (Phase 1)Looking for participantsNCT07207954
What this trial is testing

Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lifordi Immunotherapeutics, Inc. 176
Testing effectiveness (Phase 2)Ended earlyNCT05516758
What this trial is testing

Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisArthritisJoint Diseases+5 more
Eli Lilly and Company 491
Next Page